QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

 cantor-fitzgerald-reiterates-overweight-on-cigna-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna (NYSE:CI) with a Overweight and maintains $400 price target.

 rbc-capital-reiterates-outperform-on-cigna-maintains-384-price-target

RBC Capital analyst Ben Hendrix reiterates Cigna (NYSE:CI) with a Outperform and maintains $384 price target.

 jp-morgan-maintains-overweight-on-cigna-raises-price-target-to-438

JP Morgan analyst Lisa Gill maintains Cigna (NYSE:CI) with a Overweight and raises the price target from $435 to $438.

 expert-ratings-for-cigna
Expert Ratings For Cigna
08/19/2024 16:00:16

 cantor-fitzgerald-reiterates-overweight-on-cigna-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna (NYSE:CI) with a Overweight and maintains $400 price target.

 stephens--co-reiterates-overweight-on-cigna-group-maintains-410-price-target

Stephens & Co. analyst Scott Fidel reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $410 price target.

 barclays-maintains-overweight-on-cigna-group-raises-price-target-to-405

Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $393 to $405.

 us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

 cignas-q2-profit-beats-analyst-estimates-as-evernorth-health-services-growth-builds-momentum-reiterates-annual-outlook

Cigna reported Q2 sales of $60.52 billion, up 25% YoY, beating estimates. Growth was driven by Evernorth Health Services' c...

 wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION